30.01.2013 Views

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

Abstracts Posters SICOT-SOF meeting Gothenburg 2010 _2_

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Poster<br />

Topic: General Orthopaedics<br />

Abstract number: 22921<br />

PRELIMINARY EXPERIENCE WITH LOCAL HAEMOSTATIC AGENT<br />

(VITAGEL) IN TOTAL KNEE REPLACEMENT<br />

Stephenie S. J. TIEW, Aaron NG, Olufemi OYEKANMI, Aliasgar JIVANJEE, Buchi<br />

ARUMILLI<br />

Manchester Royal Infirmary, Manchester (UNITED KINGDOM)<br />

Introduction: - The purpose of this study is to ascertain the effectiveness of<br />

haemostatic agent (Vitagel) in TKRs. Material and methods: - From Feb 09 to August<br />

09, we prospectively studied 25 consecutive patients (mean age, 69.5 years; range,<br />

60 to 84 years; 17 female, 8 male). Who had undergone TKRs. Patient<br />

demographics, perioperative blood loss, the need of blood transfusion, hospital<br />

length of stay and post-operative complications were recorded. The patients were<br />

divided in two groups. In group A, 11 patients received 1 unit of Vitagel, placed in the<br />

medial gutters, lateral gutters and suprapatellar pouch prior to deep closure of<br />

implanted TKRs. In group B, 14 patients were used as control group. Results: - Both<br />

groups have similar demographic details. The study revealed no significant difference<br />

between the 2 groups with regards to hospital length of stay (5 vs.7; p> 0.05 with<br />

95% CI -3 to 0) and drop in haemoglobin level (2.4 vs. 2.3; p> 0.05 with 95% CI -1.1<br />

to 1.1). However, the blood transfusion requirement is less in group A as compared<br />

to group B (risk ration 0.778; odds ratio 0.556). No difference was observed in<br />

complication rates in both groups. Conclusion: - Hospital length of stay was<br />

shortened in group A but not statistically significant. However, there is a 10.4%<br />

absolute risk reduction for transfusion in group A compared to group B.<br />

206

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!